ADVERTISEMENT
GlaxoSmithKline in takeover bid for Human Genome Sciences
Finance Secretary RS Gujral said that there was no question of the government negotiating with any company on the tax amendments proposed in the Finance Bill for 2012-13.
09 May 2012, 02:35 PM IST 
Newly-elected French President Francois Hollande (L) with outgoing Culture Minister Frederic Mitterrand
GlaxoSmithKline has tabled an offer to take over US drugmaker Human Genome Sciences, which values the target at nearly $2.6 billion.GlaxoSmithKline, which has profit-sharing agreements with HGS on three drugs but a minimal shareholding, said Wednesday it is offering $13 cash per share for the company. A private offer last month by GSK at the same price was rejected by HGS management last month.GSK said its offer was 81 percent more t...
